Key stats
About TIGER GLOBAL OBESITY TREATMENT TOP2 PLUS
Expense ratio
0.45%
Home page
Inception date
Feb 29, 2024
ISIN
KR7476690003
The investment trusts constructs an index of listed companies in developed countries that generate revenue or conduct R&D related to obesity treatments, with the top two holdings by market capitalization representing 25% each and the remaining eight holdings weighted by market capitalization
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region
Displays a symbol's price movements over previous years to identify recurring trends.